Grant: Engage Grants Program
University of Guelph
$25,000.00
Identification and use of fungal disease resistance for improvement of medical cannabis production
EF 2016-17
Résumé
Cannabis sativa L. (marijuana) has been cultivated and used for medicinal purposes throughout human history. Cannabis contains a wide variety of active compounds, among them the well known tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN). It can be used for treatment of a range of disease-associated conditions including chronicpain, sleep disorders and nausea related to cancer treatments. Currently, producers licensed by Health Canada may sell or provide medical marijuana to eligible persons under the MMPR (Marihuana for Medical Purposes Regulations). Across the industry, yield and quality of medical marijuana products have the potential to be threatened by diseases caused by a variety of organisms, parasitic fungi in particular. This application will provide the means to understand the genetic diversity of various cannabis strains as well as the specific fungal diseases that affect them through a series of molecular and pathological approaches. The identification of resistant cannabis plants and the molecular aspects that provide that resistance will be the starting point for a state-of-theart medical marijuana selection and breeding program. Having this knowledge will significantlycontribute to enhanced yields, reductions in labor cost and decreases in potential future economic losses as a result of disease pressure. Resistant cannabis strains will benefit consumers/patients by ensuring consistency in the quality of medical marijuana products. In addition, the use of resistant cannabis strains will eliminate the need for chemical disease controls, thereby benefiting the environment and even further increasing medical marijuana quality.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
493410-2016
Name nom
Pauls, Peter
Department département
Plant Agriculture (Guelph)
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1002
Area of application group en
Northern development
Area of application group fr
Développement du nord
Area of application en
Environment
Area of application fr
Environnement
Research subject code
4906
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant pathology
Research subject fr
Phytopathologie
Partie
1
Nb partie
1
Application title
Identification and use of fungal disease resistance for improvement of medical cannabis production
Keyword
NSERC
Application summary
Cannabis sativa L. (marijuana) has been cultivated and used for medicinal purposes throughout human history. Cannabis contains a wide variety of active compounds, among them the well known tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN). It can be used for treatment of a range of disease-associated conditions including chronicpain, sleep disorders and nausea related to cancer treatments. Currently, producers licensed by Health Canada may sell or provide medical marijuana to eligible persons under the MMPR (Marihuana for Medical Purposes Regulations). Across the industry, yield and quality of medical marijuana products have the potential to be threatened by diseases caused by a variety of organisms, parasitic fungi in particular. This application will provide the means to understand the genetic diversity of various cannabis strains as well as the specific fungal diseases that affect them through a series of molecular and pathological approaches. The identification of resistant cannabis plants and the molecular aspects that provide that resistance will be the starting point for a state-of-theart medical marijuana selection and breeding program. Having this knowledge will significantlycontribute to enhanced yields, reductions in labor cost and decreases in potential future economic losses as a result of disease pressure. Resistant cannabis strains will benefit consumers/patients by ensuring consistency in the quality of medical marijuana products. In addition, the use of resistant cannabis strains will eliminate the need for chemical disease controls, thereby benefiting the environment and even further increasing medical marijuana quality.